Naronapride

Generic Name: Naronapride

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₄₁ClN_₄O_₅

CAS Number: 860174-12-5

Unique Ingredient Identifier: 058896B00B

Indication: Investigated for use/treatment in gastroesophageal reflux disease (GERD) and gastroparesis.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger

Relief Therapeutics and Renexxion sign non-binding LOI for reverse merger to create a combined entity with an expanded therapeutic pipeline, aiming to strengthen competitive position, enhance shareholder value, and accelerate delivery of innovative therapies.

Related Clinical Trials:

Different Doses of Naronapride vs. Placebo in Gastroparesis

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy